an Istitution Experience on Parosteal OsTeosarcoma

Parosteal Osteosarcoma Clinical Trial

Official title:

Parosteal OsTeosarcoma: a Single Istitution Experience

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03768076
• Other study ID #: POsT
• Status: Completed
• Start date: November 30, 2018
• Est. completion date: February 28, 2019

Study information

• Verified date: July 2021
• Source: Istituto Ortopedico Rizzoli
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

single institution cases series review of histological and clinical data

Description:

Investigators will review all the cases with a diagnosis of primary parosteal osteosarcoma treated at the Rizzoli Institute from 1900 up to 31 July 2018, retrospectively.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 220
• Est. completion date: February 28, 2019
• Est. primary completion date: February 28, 2019
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Male and female patients treated at Rizzoli Institute from 01 Jan 1900 to 31 Jul 2018

• Diagnosis of parosteal osteosarcoma

• Written informed consent prior to any study-specific analysis and/or data collection

Exclusion Criteria:

• Patients with histological diagnosis different from parosteal osteosarcoma

Related Conditions & MeSH terms

• Osteosarcoma
• Parosteal Osteosarcoma

Locations

Country	Name	City	State
Italy	Istituto ortopedico Rizzoli	Bologna

Sponsors (1)

Lead Sponsor	Collaborator
Istituto Ortopedico Rizzoli

Country where clinical trial is conducted

Italy, 

References & Publications (4)

Bertoni F, Bacchini P, Staals EL, Davidovitz P. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli Institute. Cancer. 2005 Jun 1;103(11):2373-82. — View Citation

Han I, Oh JH, Na YG, Moon KC, Kim HS. Clinical outcome of parosteal osteosarcoma. J Surg Oncol. 2008 Feb 1;97(2):146-9. — View Citation

Laitinen M, Parry M, Albergo JI, Jeys L, Abudu A, Carter S, Sumathi V, Grimer R. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J. 2015 Dec;97-B(12):1698-703. doi: 10.1302/0301-620X.97B — View Citation

Okada K, Frassica FJ, Sim FH, Beabout JW, Bond JR, Unni KK. Parosteal osteosarcoma. A clinicopathological study. J Bone Joint Surg Am. 1994 Mar;76(3):366-78. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	retrospective analysis of cases of Parosteal osteosarcoma	Investigators will exam the presence of progression (dedifferentiation) areas and the relationship of these factors to individual outcome.	at baseline (Day0)